VICTOR GUNN: Open Payments
NPI 1164857058 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,171 in 156 payments from 32 companies in 2025. Trend: 2023 $2,623 · 2024 $2,560 · 2025 $3,171
Food & beverage: $3,171
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $479 |
| Amgen Inc. | 15 | $310 |
| Novo Nordisk Inc | 15 | $232 |
| Axsome Therapeutics, Inc. | 8 | $213 |
| Lilly USA, LLC | 6 | $198 |
| Corcept Therapeutics | 3 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $165 |
| GlaxoSmithKline, LLC. | 12 | $163 |
| PFIZER INC. | 10 | $154 |
| Boston Scientific Corporation | 1 | $142 |
Products named: JARDIANCE, VRAYLAR, Korlym, General - Therapies, Symbravo, Ozempic, UBRELVY, SHINGRIX.
Industry payments across CA — which companies pay providers there.
